The success of Viagra initially sparked a period of growth for pharma, but recent shifts present a complicated outlook for investors. Lower-cost competitors are eroding revenue, and continued litigation add further https://albertetaw142847.blogunteer.com/39894345/viagra-and-big-pharma-a-risky-play